Recombinant Staphylococcus aureus Peptide chain release factor 1 (prfA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipment, contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us, and we will prioritize its development.
Synonyms
prfA; NWMN_2022; Peptide chain release factor 1; RF-1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-358
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Staphylococcus aureus (strain Newman)
Target Names
prfA
Target Protein Sequence
MFDQLDIVEE RYEQLNELLS DPDVVNDSDK LRKYSKEQAD LQKTVDVYRN YKAKKEELAD IEEMLSETDD KEEVEMLKEE SNGIKAELPN LEEELKILLI PKDPNDDKDV IVEIRAAAGG DEAAIFAGDL MRMYSKYAES QGFKTEIVEA SESDHGGYKE ISFSVSGNGA YSKLKFENGA HRVQRVPETE SGGRIHTSTA TVAVLPEVED VEIEIRNEDL KIDTYRSSGA GGQHVNTTDS AVRITHLPTG VIATSSEKSQ IQNREKAMKV LKARLYDMKV QEEQQKYASQ RKSAVGTGDR SERIRTYNYP QSRVTDHRIG LTLQKLGQIM EGHLEEIIDA LTLSEQTDKL KELNNGEL
Uniprot No.

Target Background

Function
Peptide chain release factor 1 terminates translation in response to the stop codons UAG and UAA.
Database Links
Protein Families
Prokaryotic/mitochondrial release factor family
Subcellular Location
Cytoplasm.

Q&A

What is PrfA in Staphylococcus aureus and what are its primary cellular functions?

PrfA (Peptide chain release factor 1) in S. aureus is a multifunctional protein involved in several essential cellular processes. Based on studies in related Gram-positive bacteria, particularly Bacillus species, PrfA participates in:

  • Cell wall synthesis

  • Chromosome segregation

  • DNA recombination and repair

This multifunctionality makes PrfA unusual among bacterial proteins, as most proteins specialize in fewer cellular processes. The protein is co-transcribed with the ponA gene in both B. subtilis and S. aureus, indicating a conserved genetic organization that suggests functional importance .

How is the prfA gene organized in S. aureus compared to other bacterial species?

The prfA gene in S. aureus is located in an operon with ponA, similar to its organization in B. subtilis. This conservation of gene arrangement between S. aureus and Bacillus species suggests functional importance:

  • In B. subtilis, prfA is cotranscribed with the ponA gene, which encodes a Class A penicillin-binding protein

  • This same arrangement is preserved in S. aureus, reinforcing a functional link between PrfA and cell wall synthesis proteins

  • This conserved organization suggests that PrfA's role in cell wall synthesis may be similar across these Gram-positive bacterial species

What experimental approaches have established PrfA's involvement in multiple cellular processes?

Research has employed several methodologies to establish PrfA's multifunctional nature:

  • Genetic analysis: Inactivation of prfA in B. subtilis reduces growth rate by approximately 50%, while simultaneous mutation of ponA and prfA has more severe effects on growth and sporulation than either individual mutation

  • Molecular biology techniques: The prfA gene was initially identified through its cotranscription with ponA, suggesting a role in cell wall synthesis, but was later implicated in DNA recombination when studied under its alternative name recU

  • Biochemical characterization: Analysis of purified PrfA protein demonstrated endonuclease activity on DNA, supporting its role in DNA recombination and repair

What is the molecular structure of S. aureus PrfA and how does it relate to function?

Structural analysis has revealed important insights about PrfA:

  • Structural relationship: PrfA shows unexpected structural homology to the restriction enzyme PvuII, despite no obvious sequence similarity

  • DNA binding prediction: This structural relationship predicts that PrfA binds DNA, which has been experimentally confirmed

  • Functional domains: The protein likely contains distinct domains for its multiple functions, including DNA binding, catalytic activity, and potential protein-protein interactions

What is the oligomeric state of PrfA in solution and how does this influence its activity?

Studies on PrfA's oligomeric state provide important insights:

  • Sedimentation analysis: Velocity band and boundary analysis clearly show that Bacillus subtilis PrfA exists as a dimer in solution, with a molecular weight of approximately 48 kD (24 kD per monomer)

  • Concentration-dependent behavior: While size-exclusion chromatography suggests monomeric behavior at very low concentrations (<0.01 mg/mL), at higher, more physiologically relevant concentrations (~1 mg/mL), the protein exists as a dimer

  • Structural modeling: Analysis shows that the dimer structure ranks higher than monomeric forms in terms of stability, with favorable interactions at the dimer interface and unfavorable exposure of interface residues to solvent in monomeric form

What evidence supports PrfA's DNA binding capabilities and how can this be experimentally validated?

Multiple lines of evidence support PrfA's DNA binding function:

  • Structural prediction: The structural relationship with PvuII restriction enzyme suggests DNA binding capability

  • Direct biochemical evidence: Wild-type Bacillus stearothermophilus PrfA nicks one strand of supercoiled plasmid templates, leaving 5'-phosphate and 3'-hydroxyl termini

  • Mutational analysis: Catalytic site mutants lack this nicking activity, confirming the specificity of the reaction

To experimentally validate DNA binding:

  • Electrophoretic mobility shift assays (EMSA) with purified recombinant PrfA and various DNA substrates

  • DNase I footprinting to identify specific binding sites

  • Surface plasmon resonance to measure binding kinetics and affinity

What is the substrate specificity of PrfA's endonuclease activity and what are its biochemical characteristics?

PrfA demonstrates selective substrate preferences:

  • Substrate hierarchy: Activity is much higher on supercoiled plasmid templates compared to linear or relaxed circular double-stranded DNA or single-stranded DNA

  • DNA end chemistry: The nicking activity produces 5'-phosphate and 3'-hydroxyl termini, similar to many restriction enzymes

  • Functional significance: This substrate preference is consistent with a role in chromosome segregation, DNA recombination, or DNA repair, where supercoiled DNA is often the physiologically relevant substrate

How do experimental conditions affect PrfA's endonuclease activity and what are the optimal assay parameters?

Based on available research, several factors influence PrfA endonuclease activity:

  • DNA topology: Supercoiled substrates are preferred over relaxed or linear DNA, suggesting topology recognition plays a key role

  • Reaction conditions: Standard endonuclease assay conditions likely include divalent metal ions (Mg²⁺) as cofactors

  • Detection methods: Activity can be monitored by:

    • Agarose gel electrophoresis to visualize conversion of supercoiled DNA to nicked forms

    • Analysis of reaction products to confirm 5'-phosphate and 3'-hydroxyl termini

    • Comparison between wild-type protein and catalytic mutants

What is the mechanism of PrfA's involvement in cell wall synthesis and how does it interact with penicillin-binding proteins?

PrfA's role in cell wall synthesis is evidenced by:

  • Genetic organization: Co-transcription with ponA, which encodes a penicillin-binding protein with transglycosylase and transpeptidase activities

  • Mutant phenotypes: Inactivation of prfA reduces cell growth rate by approximately 50%

  • Synergistic effects: Simultaneous mutation of ponA and prfA has much more dramatic effects on cell growth and sporulation than either individual mutation

The exact mechanism of interaction between PrfA and penicillin-binding proteins remains to be fully elucidated, but the genetic arrangement suggests functional coordination in cell wall biosynthesis processes.

How does PrfA expression correlate with cell growth phases and environmental conditions?

While the search results don't provide specific information about PrfA expression patterns, research on related bacterial proteins suggests:

  • Growth phase regulation: Expression may vary between exponential and stationary phases

  • Environmental responsiveness: Factors like nutrient availability, cell density, or stress conditions may modify expression

  • Coordination: Expression levels likely correlate with cell wall synthesis needs, which vary throughout the bacterial lifecycle

This represents an important area for future investigation using techniques like qPCR, RNA-seq, or reporter gene fusions.

What expression systems are most effective for producing recombinant S. aureus PrfA and what are the key optimization parameters?

Based on successful protein production approaches for related bacterial proteins:

Expression ParameterRecommended ApproachRationale
Host systemE. coli BL21(DE3)Reduces proteolysis, high yield
VectorpET with T7 promoterTight regulation, high expression
Fusion tagsHis6 or GSTFacilitates purification
Induction0.1-0.5 mM IPTG, OD600 ~0.6-0.8Optimizes protein folding
Temperature16-25°C post-inductionEnhances solubility
MediaLB or 2xYT with glucoseSupports high cell density

Optimization should focus on:

  • Maximizing soluble protein yield

  • Ensuring proper folding and oligomeric state

  • Preserving enzymatic activity

What purification strategies yield the highest purity and activity of recombinant PrfA?

A multi-step purification approach is recommended:

  • Initial capture: Affinity chromatography using His-tag or GST-tag

  • Intermediate purification: Ion exchange chromatography to separate based on charge properties

  • Polishing: Size exclusion chromatography to:

    • Achieve final purity

    • Separate dimeric from monomeric forms

    • Transfer to storage buffer

Quality control should include:

  • SDS-PAGE and Western blotting to confirm purity and identity

  • Activity assays to confirm endonuclease function

  • Dynamic light scattering to assess oligomeric state

What are the most reliable assays for validating the activity and structural integrity of purified recombinant PrfA?

Multiple complementary approaches ensure proper characterization:

  • Endonuclease activity assays:

    • Incubation with supercoiled plasmid DNA

    • Analysis by agarose gel electrophoresis

    • Comparison with catalytic site mutants as negative controls

  • Structural integrity assessments:

    • Circular dichroism to evaluate secondary structure content

    • Thermal shift assays to determine stability

    • Size exclusion chromatography to confirm dimeric state

  • DNA binding assays:

    • Electrophoretic mobility shift assays

    • Fluorescence anisotropy with labeled DNA

    • Isothermal titration calorimetry for binding thermodynamics

What is the mechanism of PrfA's involvement in DNA recombination and how does it compare to dedicated recombination enzymes?

PrfA's role in DNA recombination has been established through:

  • Alternative naming: The prfA gene was alternatively named recU, reflecting its role in recombination

  • Functional evidence: Biochemical activities consistent with recombination functions, including DNA binding and endonuclease activity

  • Structural insights: Homology to restriction enzymes suggests mechanisms for recognizing and processing DNA structures

The endonuclease activity likely plays a crucial role in processing recombination intermediates, potentially including:

  • Holliday junctions

  • D-loop structures

  • Other branched DNA substrates

How does PrfA contribute to bacterial DNA repair processes and genome stability?

The involvement of PrfA in DNA repair processes can be inferred from:

  • Multifunctionality: The protein's ability to nick DNA suggests potential roles in various repair pathways

  • Substrate preference: Higher activity on supercoiled DNA indicates potential recognition of DNA structures that arise during repair processes

  • Genetic context: Association with both cell wall synthesis and DNA metabolism suggests a potential role in coordinating these processes during stress responses or DNA damage

This represents an area where additional research is needed to fully elucidate the specific repair pathways in which PrfA participates.

How conserved is PrfA across different bacterial species and what does this reveal about its evolutionary importance?

While the search results don't provide comprehensive comparative data, they indicate:

  • Functional conservation: PrfA appears to serve similar roles in both Bacillus species and S. aureus

  • Structural conservation: The operon arrangement with ponA is preserved between B. subtilis and S. aureus

  • Multifunctionality: The unusual combination of functions (cell wall synthesis, DNA recombination) appears conserved, suggesting evolutionary importance

A more comprehensive phylogenetic analysis would reveal the extent of conservation across broader bacterial taxa and potentially identify specialized adaptations in different lineages.

How do PrfA homologs differ functionally between Staphylococcus aureus and other Gram-positive bacteria?

While detailed comparative functional data is limited, the search results suggest:

  • Similar genetic organization: The prfA gene in S. aureus is located in an operon with ponA, as in B. subtilis

  • Conserved multifunctionality: Involvement in both cell wall synthesis and DNA metabolism appears to be a shared feature

  • Species-specific adaptations: Differences in regulation, activity levels, or interaction partners may exist but require further investigation

What is the potential of targeting PrfA for antimicrobial development and what experimental approaches would validate this target?

Given PrfA's involvement in multiple essential cellular processes, it represents a potential antimicrobial target:

  • Essential functions: Roles in both cell wall synthesis and DNA metabolism make it potentially essential for bacterial viability

  • Unique activities: The endonuclease activity and structural features might allow for selective targeting

  • Conserved nature: Presence across multiple Gram-positive pathogens could enable broad-spectrum activity

Validation approaches would include:

  • Conditional knockdown strains to confirm essentiality

  • High-throughput screening for inhibitors of PrfA's endonuclease activity

  • Structure-based drug design targeting the catalytic site or dimerization interface

How might inhibition of PrfA's different functions differentially affect S. aureus physiology and virulence?

Selective inhibition strategies could target different aspects of PrfA function:

  • Endonuclease inhibition: May disrupt DNA recombination and repair, potentially sensitizing bacteria to DNA-damaging agents

  • Protein-protein interaction disruption: Could interfere with cell wall synthesis by preventing coordination with penicillin-binding proteins

  • Expression modulation: Altering PrfA levels might unbalance multiple cellular processes simultaneously

The multifunctional nature of PrfA suggests that inhibition might produce synergistic effects across multiple essential pathways, potentially reducing the likelihood of resistance development.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.